Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012
Research

HIV Infection and Geographically Bound Transmission of Drug-Resistant Tuberculosis, Argentina

Viviana RitaccoComments to Author , Beatriz López, Marta Ambroggi, Domingo Palmero, Bernardo Salvadores, Elida Gravina, Eduardo Mazzeo, Susana Imaz, Lucía Barrera, and National TB Laboratory Network
Author affiliations: Instituto Nacional de Enfermedades Infecciosas ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina (V. Ritacco, B. López, E. Mazzeo, L. Barrera); Hospital “Dr. F.J. Muñiz,” Buenos Aires (M. Ambroggi, D. Palmero); Programa Provincial de Tuberculosis, Santa Fe, Argentina (B. Salvadores); Hospital Zonal General Agudos “Dr. Diego Paroissien,” La Matanza, Argentina (E. Gravina); and Instituto Nacional de Enfermedades Respiratorias “Dr. Emilio Coni” ANLIS “Dr Carlos G Malbran,” Santa Fe (S. Imaz)

Main Article

Table 6

Characteristics of 53 patients with extensively drug-resistant TB, Argentina 2003–2009*

Characteristic No. patients % In cluster % In major cluster
Sex

M

 29 79.3 58.6

F

 24 75.0 58.3
Age group, y

15–29

 16 81.3 50.0

30–44

 24 75.0 66.7

>45

 8 87.5 50.0

Unknown (adult)

 5 60.0 60.0
Country of birth
Argentina 30 76.7 53.3

Other (South America)†

 11 81.8 63.6

Unknown (South America)‡

 11 81.8 72.7

Indonesia

 1 0 0
Place of diagnosis

Former MDR TB hot spot

 31 74.2 71.0

Other

 22 81.8 40.9
HIV status

Positive

 14 85.7 78.6

Negative

 33 75.8 54.5

Unknown

 6 66.7 33.3
Site of disease

Pulmonary

 49 81.6 61.2

Disseminated

 3 33.3 33.3

Unknown

 1 0 0
Previous TB

Yes

 38 71.1 50.0

No

 10 90.0 70.0

Unknown

 5 100.0 100.0
AFB smear microscopy

Positive

 41 78.0 56.1

Negative

 7 71.4 57.1

Unknown

 5 75.0 75.0

*TB, tuberculosis; MDR, multidrug-resistant; AFB, acid-fast bacilli.
†From a country in South America other than Argentina
‡From an unknown country in South America.

Main Article

1Additional members of the National TB Laboratory Network who contributed data are listed at the end of this article.

Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external